Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model
- 14 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 34 (7), 1721-1732
- https://doi.org/10.1038/npp.2008.229
Abstract
Chromatin modification through histone acetylation is a molecular pathway involved in the regulation of transcription underlying memory storage. Sodium 4-phenylbutyrate (4-PBA) is a well-known histone deacetylase inhibitor, which increases gene transcription of a number of genes, and also exerts neuroprotective effects. In this study, we report that administration of 4-PBA reversed spatial learning and memory deficits in an established mouse model of Alzheimer's disease (AD) without altering β-amyloid burden. We also observed that the phosphorylated form of tau was decreased in the AD mouse brain after 4-PBA treatment, an effect probably due to an increase in the inactive form of the glycogen synthase kinase 3β (GSK3β). Interestingly, we found a dramatic decrease in brain histone acetylation in the transgenic mice that may reflect an indirect transcriptional repression underlying memory impairment. The administration of 4-PBA restored brain histone acetylation levels and, as a most likely consequence, activated the transcription of synaptic plasticity markers such as the GluR1 subunit of the AMPA receptor, PSD95, and microtubule-associated protein-2. The results suggest that 4-PBA, a drug already approved for clinical use, may provide a novel approach for the treatment of AD.This publication has 57 references indexed in Scilit:
- Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disordersCurrent Opinion in Pharmacology, 2008
- The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fearLearning & Memory, 2008
- Chromosomal profiles of gene expression in Huntington's diseaseBrain, 2007
- Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapsesNeurobiology of Disease, 2005
- The Persistence of Long-Term MemoryNeuron, 2004
- Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating AnimalsJournal of Neuroscience, 2003
- Treatment of spinal muscular atrophy by sodium butyrateProceedings of the National Academy of Sciences of the United States of America, 2001
- Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primateCancer Chemotherapy and Pharmacology, 2001
- Positive and negative regulatory mechanisms that mediate long-term memory storageBrain Research Reviews, 1998
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991